The Effect of Facial Effleurage on Acute Rhinosinusitis
Status:
Completed
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
Rhinosinusitis accounts for 12% of the total antibiotic prescriptions filled in the United
States annually; however, the majority of rhinosinusitis cases have been proposed to have a
viral etiology, or are capable of spontaneously resolving. This overuse of antibiotics is
contributing to the development of antibiotic-resistant human pathogenic bacteria, and
increasing patient mortality to previously easily cured diseases. This is also causing an
unnecessary financial burden especially for uninsured, rural families. Facial Effleurage (FE)
is an osteopathic manipulative therapy that allows physicians an alternative therapy to
prescribing antibiotics; however, the only scientific literature on the technique is weak in
design and execution. This will be a randomized, placebo-controlled clinical trial to test
the ability of FE to reduce symptom severity over time, reduce the cellular infiltrate into
the nasal cavity, and to more quickly resolve the symptoms of rhinosinusitis compared to
antibiotic treatment. This methodical approach to the efficacy of FE has the potential to
impact the treatment recommendations of physicians immediately, and to convince more
physicians to prescribe less antibiotics and rely more heavily on FE.
Phase:
N/A
Details
Lead Sponsor:
Edward Via Virginia College of Osteopathic Medicine